Lymph node harvest in colon and rectal cancer: Current considerations.
AffiliationDepartment of Surgery, The Christie NHS Foundation Trust, Manchester M20 4BX, United Kingdom.
MetadataShow full item record
AbstractThe prognostic significance of identifying lymph node (LN) metastases following surgical resection for colon and rectal cancer is well recognized and is reflected in accurate staging of the disease. An established body of evidence exists, demonstrating an association between a higher total LN count and improved survival, particularly for node negative colon cancer. In node positive disease, however, the lymph node ratios may represent a better prognostic indicator, although the impact of this on clinical treatment has yet to be universally established. By extension, strategies to increase surgical node harvest and/or laboratory methods to increase LN yield seem logical and might improve cancer staging. However, debate prevails as to whether or not these extrapolations are clinically relevant, particularly when very high LN counts are sought. Current guidelines recommend a minimum of 12 nodes harvested as the standard of care, yet the evidence for such is questionable as it is unclear whether an increasing the LN count results in improved survival. Findings from modern treatments, including down-staging in rectal cancer using pre-operative chemoradiotherapy, paradoxically suggest that lower LN count, or indeed complete absence of LNs, are associated with improved survival; implying that using a specific number of LNs harvested as a measure of surgical quality is not always appropriate. The pursuit of a sufficient LN harvest represents good clinical practice; however, recent evidence shows that the exhaustive searching for very high LN yields may be unnecessary and has little influence on modern approaches to treatment.
CitationLymph node harvest in colon and rectal cancer: Current considerations. 2012, 4 (1):9-19 World J Gastrointest Surg
JournalWorld Journal of Gastrointestinal Surgery
- Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
- Authors: Zeng WG, Zhou ZX, Wang Z, Liang JW, Hou HR, Zhou HT, Zhang XM, Hu JJ
- Issue date: 2014
- Lymph node identification following neoadjuvant therapy in rectal cancer: A stage-stratified analysis using the surveillance, epidemiology, and end results (SEER)-medicare database.
- Authors: Ecker BL, Paulson EC, Datta J, Jeganathan AN, Aarons C, Kelz RR, Mahmoud NN
- Issue date: 2015 Sep
- The impact of complete embedding of remaining tissue in gynecological lymph node dissection specimen in surgical pathology on lymph node yield: is it clinically relevant?
- Authors: Andruszkow J, Meinhold-Heerlein I, Winkler B, Bruno B, Knüchel R, Jäkel J
- Issue date: 2018 Aug
- Lymph node counts and survival rates after resection for colon and rectal cancer.
- Authors: Wong SL
- Issue date: 2009 Mar
- Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study.
- Authors: Chou JF, Row D, Gonen M, Liu YH, Schrag D, Weiser MR
- Issue date: 2010 Jun 1